Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
I-Flow Corporation
I-Flow Reports 21% Increase in Total Revenues for the Second Quarter of 2008 to $35.3 Million Versus $29.1 Million for the Second Quarter of 2007
August 24th, 2008
I-FLOW CORPORATION (NASDAQ:IFLO) announced that total revenue from continuing operations in the second quarter increased 21% to a record $35.3 million compared to $29.1 million for the same period of the prior year. Sales of Acute Care products, which include Regional Anesthesia (RA) sales of the Company's flagship ON-Q(R) product lines and AcryMed revenues, increased 21% for the second quarter of 2008 to $27.9 million compared to $23.0 million for the second quarter of 2007. The loss from continuing operations before income taxes for this year's second quarter was $11.5 million. The $11.5 million loss amount included $12.2 million of certain litigation and insurance...
Source: Pharma Investments, Ventures & Law Weekly (2008-08-24)
|
